Synovics Pharmaceuticals Beta vs. Current Asset
| SYVC Stock | USD 0.0001 0.00 0.00% |
For Synovics Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Synovics Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Synovics Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Synovics Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Synovics Pharmaceuticals over time as well as its relative position and ranking within its peers.
Check out World Market Map. Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synovics Pharmaceuticals. If investors know Synovics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synovics Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Synovics Pharmaceuticals is measured differently than its book value, which is the value of Synovics that is recorded on the company's balance sheet. Investors also form their own opinion of Synovics Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Synovics Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synovics Pharmaceuticals' market value can be influenced by many factors that don't directly affect Synovics Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synovics Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Synovics Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synovics Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Synovics Pharmaceuticals Current Asset vs. Beta Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Synovics Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Synovics Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Synovics Pharmaceuticals is currently regarded as top stock in beta category among its peers. It is rated third in current asset category among its peers fabricating about 28,633 of Current Asset per Beta. As of December 28, 2025, Other Current Assets is expected to decline to about 255.1 K. In addition to that, Total Current Assets is expected to decline to about 5.7 M. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Synovics Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Synovics Current Asset vs. Beta
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Synovics Pharmaceuticals |
| = | 163.31 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Synovics Pharmaceuticals |
| = | 4.68 M |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Synovics Current Asset Comparison
Synovics Pharmaceuticals is currently under evaluation in current asset category among its peers.
Beta Analysis
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Synovics Pharmaceuticals will likely underperform.
Synovics Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Synovics Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Synovics Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Synovics Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Synovics Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -2.2 M | -2.3 M | |
| Net Loss | -3.6 M | -3.8 M | |
| Income Before Tax | -3.6 M | -3.8 M | |
| Total Other Income Expense Net | -1.4 M | -1.4 M | |
| Net Loss | -3.6 M | -3.8 M | |
| Net Loss | -3.6 M | -3.8 M | |
| Change To Netincome | 5.2 M | 4.7 M | |
| Net Loss | (0.15) | (0.16) | |
| Income Quality | (1.11) | (1.05) | |
| Net Income Per E B T | 1.02 | 0.89 |
Synovics Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Synovics Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Synovics Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Synovics Pharmaceuticals' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Synovics Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Use Investing Themes to Complement your Synovics Pharmaceuticals position
In addition to having Synovics Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Casinos Thematic Idea Now
Casinos
Companies that are related to providing casino-type services across multiple geographical areas. The Casinos theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Casinos Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. For information on how to trade Synovics Stock refer to our How to Trade Synovics Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
To fully project Synovics Pharmaceuticals' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Synovics Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Synovics Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows.